Drugs / Cs-C-Q80
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05890573 | Apr → May 2024 | pneumonia, pulmonary fibrosis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cs-C-Q80 | “The ingredient of Bailing capsule is Cs-C-Q80,it has obvious protective effect on lung.” NCT05890573 ↗ |